Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc.verified

AUPH

Price:

$5.21

Market Cap:

$745.13M

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.[Read more]

Industry

Biotechnology

IPO Date

2014-09-03

Stock Exchange

NASDAQ

Ticker

AUPH

The PE Ratio as of May 2024 (TTM) for Aurinia Pharmaceuticals Inc. (AUPH) is -12.12

According to Aurinia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -12.12. This represents a change of -40.01% compared to the average of -20.20 of the last 4 quarters.

Aurinia Pharmaceuticals Inc. (AUPH) Historical PE Ratio (quarterly & annually)

How has AUPH PE Ratio performed in the past?

The mean historical PE Ratio of Aurinia Pharmaceuticals Inc. over the last ten years is -9.78. The current -12.12 PE Ratio has changed 12.30% with respect to the historical average. Over the past ten years (40 quarters), AUPH's PE Ratio was at its highest in in the March 2017 quarter at -2.00. The PE Ratio was at its lowest in in the December 2020 quarter at -54.22.

Quarterly (TTM)
Annual

Average

-9.78

Median

-7.68

Minimum

-16.50

Maximum

-3.18

Aurinia Pharmaceuticals Inc. (AUPH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aurinia Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 191.23%

Maximum Annual PE Ratio = -3.18

Minimum Annual Increase = -65.34%

Minimum Annual PE Ratio = -16.50

Quarterly (TTM)
Annual
YearPE RatioChange
2023-16.50191.23%
2022-5.67-65.34%
2021-16.352.46%
2020-15.964.86%
2019-15.2268.76%
2018-9.0271.12%
2017-5.2765.67%
2016-3.18-25.48%
2015-4.27-32.66%
2014-6.34-34.78%

Aurinia Pharmaceuticals Inc. (AUPH) Average PE Ratio

How has AUPH PE Ratio performed in the past?

The current PE Ratio of Aurinia Pharmaceuticals Inc. (AUPH) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-12.84

5-year avg

-13.94

10-year avg

-9.78

Aurinia Pharmaceuticals Inc. (AUPH) PE Ratio vs. Peers

How is AUPH’s PE Ratio compared to its peers?

Aurinia Pharmaceuticals Inc.’s PE Ratio is greater than Viking Therapeutics, Inc. (-69.27), less than Axsome Therapeutics, Inc. (-12.02), less than Madrigal Pharmaceuticals, Inc. (-10.34), greater than ImmunoGen, Inc. (-122.93), less than Seres Therapeutics, Inc. (-1.62), less than Exelixis, Inc. (30.17), less than TG Therapeutics, Inc. (59.30), less than BioXcel Therapeutics, Inc. (-0.38), less than Sarepta Therapeutics, Inc. (686.76), less than Hepion Pharmaceuticals, Inc. (-0.15), less than PTC Therapeutics, Inc. (-4.91), less than Intercept Pharmaceuticals, Inc. (0), greater than Terns Pharmaceuticals, Inc. (-13.55), less than Akero Therapeutics, Inc. (-4.90), less than Reata Pharmaceuticals, Inc. (-6.06), greater than null (-89.36),

Build a custom stock screener for Aurinia Pharmaceuticals Inc. (AUPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aurinia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aurinia Pharmaceuticals Inc. (AUPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aurinia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Aurinia Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for Aurinia Pharmaceuticals Inc. (AUPH)?

What is the highest PE Ratio for Aurinia Pharmaceuticals Inc. (AUPH)?

What is the 3-year average PE Ratio for Aurinia Pharmaceuticals Inc. (AUPH)?

What is the 5-year average PE Ratio for Aurinia Pharmaceuticals Inc. (AUPH)?

How does the current PE Ratio for Aurinia Pharmaceuticals Inc. (AUPH) compare to its historical average?